Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-07-26

FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

The FDA granted supplemental approval for a fixed-dose combination product of amlodipine and atorvastatin by Prasco Laboratories. This approval enables the mark…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and Atorvastatin (amlodipine besylate and atorvastatin calcium)

Snippet

SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)